Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature

被引:27
作者
Long, Wenyong [1 ]
Yuan, Jian [1 ]
Liu, Jingping [1 ]
Liu, Jinfang [1 ]
Wu, Ming [1 ]
Chen, Xin [1 ]
Peng, Gang [1 ]
Wu, Changwu [1 ]
Zhang, Chi [1 ]
Wang, Xiangyu [1 ]
Zhao, Wei [2 ]
Liu, Qing [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
基金
中国国家自然科学基金;
关键词
intracranial infection; multidrug-resistant; tigecycline therapy; Acinetobacter baumannii; ventriculitis; MENINGITIS; COLISTIN; INFECTIONS; MANAGEMENT;
D O I
10.3389/fneur.2018.00518
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Ventricular infection from multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) is one of the severe complications of craniotomy. However, the availability of effective therapeutic options for these infections are limited. Thus, this report aimed to describe the efficacy of abscess clearance by intraventricular and intravenous tigecycline therapy in managing patients with multidrug-resistant A. baumannii ventriculitis after neurosurgery. Moreover, the current literature on the use of tigecycline therapy for these life-threatening infections is reviewed and summarized, and a treatment regimen based on the available data was proposed. Methods: A patient with multidrug-resistant A. baumannii ventriculitis was admitted in our hospital and was provided with a detailed therapeutic schedule. Tigecycline treatments for multidrug-resistant A. baumannii ventriculitis that were reported in the literature were also reviewed and summarized. Results: The patient in our hospital underwent abscess clearance on a ventriculoscope and was subsequently subjected to multi-route tigecycline therapy 14 days after the start of the continuous ventricular irrigation (CVI) tigecycline and 3 days after the intraventricular (IVT) tigecycline. The signs of ventriculitis disappeared, and the Acinetobacter cerebrospinal fluid (CSF) load steadily decreased until CSF sterilization. Literature review identified seven cases of ventricular infection from multidrug-resistant A. baumannii treated with tigecycline. In the eight cases, all patients were male adults (> 18 years), with a mean age of 46.1 (range: 22-75) years. Meningitis/ventriculitis was secondary to neurosurgery procedures for the management of various central nervous system diseases in all cases. A good clinical outcome was achieved in all eight patients with multidrug-resistant A. baumannii meningitis/ventriculitis treated with CVI and/or IVT tigecycline, and any relevant complications were not observed. Conclusions : CVI and IVT tigecycline and IVT colistin could be considered as the first-line therapy in patients with ventricular infections from MDR/extreme drug-resistant A. baumannii. However, more studies should be conducted to confirm our observation.
引用
收藏
页数:7
相关论文
共 14 条
  • [1] De Pascale G, 2010, MINERVA ANESTESIOL, V76, P957
  • [2] Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
    Entenza, J. M.
    Moreillon, P.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (01)
  • [3] A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii
    Fang, Yu-Qing
    Zhan, Ru-Cai
    Jia, Wei
    Zhang, Bao-Qing
    Wang, Jian-Jun
    [J]. MEDICINE, 2017, 96 (31)
  • [4] Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
    Karageorgopoulos, Drosos E.
    Falagas, Matthew E.
    [J]. LANCET INFECTIOUS DISEASES, 2008, 8 (12) : 751 - 762
  • [5] Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review
    Karaiskos, Ilias
    Galani, Lambrini
    Baziaka, Fotini
    Giamarellou, Helen
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (06) : 499 - 508
  • [6] Management of meningitis due to antibiotic-resistant Acinetobacter species
    Kim, Baek-Nam
    Peleq, Anton Y.
    Lodise, Thomas P.
    Lipman, Jeffrey
    Li, Jian
    Nation, Roger
    Paterson, David L.
    [J]. LANCET INFECTIOUS DISEASES, 2009, 9 (04) : 245 - 255
  • [7] Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline
    Kooli, Ikbel
    Ben Brahim, Hajer
    Kilani, Mohamed
    Gannouni, Chokri
    Aouam, Abir
    Toumi, Adnene
    Loussaief, Chawki
    Hattab, Mohamed Nejib
    Chakroun, Mohamed
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 5 : 62 - 63
  • [8] First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii
    Lauretti, Liverana
    D'Alessandris, Quintino Giorgio
    Fantoni, Massimo
    D'Inzeo, Tiziana
    Fernandez, Eduardo
    Pallini, Roberto
    Scoppettuolo, Giancarlo
    [J]. JOURNAL OF NEUROSURGERY, 2017, 127 (02) : 370 - 373
  • [9] Treatment of Acinetobacter infections
    Michalopoulos, Argyris
    Falagas, Matthew E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) : 779 - 788
  • [10] Tigecycline
    Pankey, GA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) : 470 - 480